AXA/2025/FY/Earnings presentation: Difference between revisions
Content deleted Content added
PlumBot: publish from draft |
Migrate infobox: document_type -> document_category; add specific form as document_type |
||
| (3 intermediate revisions by the same user not shown) | |||
Line 4:
| period = FY
| period_label = FY25
|
| publication_date = 2026-02-26
| language = English
Line 18:
=== Full Year 2025 earnings presentation ===
* ''
=== Important legal information and cautionary statements concerning forward-looking statements and the use of non-GAAP financial measures ===
*
* ''Expected UEPS growth'' for 2026 is provided as one-off guidance in the context of the final year of the Group's current strategic plan <sup>p. 2</sup>.
* ''Risk factors'' and uncertainties that may affect AXA's business are described in Part 5 "Risk Factors and Risk Management" of AXA's 2024 Universal Registration Document <sup>p. 2</sup>.
* ''
** APMs are defined under ESMA guidelines and the AMF's 2015 position statement, with reconciliations provided in AXA's 2025 Activity Report <sup>p. 2</sup>.
* ''Financial statements status'': AXA's consolidated financial statements for the year ended December 31, 2025 were examined by the Board of Directors on February 25, 2026, and are subject to completion of audit procedures <sup>p. 2</sup>.
=== Table of contents ===
*
*
*
== FY25 Highlights ==
*
=== Full Year 2025 | Excellent performance ===
Line 46 ⟶ 47:
! class="col-m" style="text-align:right" | Value
|-
| style="text-align:left" | Revenues growth vs. FY24
| style="text-align:right" | +6%
|-
| style="text-align:left" | Underlying EPS growth vs. FY24
| style="text-align:right" | +8%
|-
Line 58 ⟶ 59:
| style="text-align:right" | 224%
|-
| style="text-align:left" |
| style="text-align:right" | +8%
|-
| style="text-align:left" |
| style="text-align:right" | EUR 1.25bn
|-
| style="text-align:left" | Underlying EPS
| style="text-align:right" |
|}
</div>
* Dividend proposal based on Board of Directors' recommendation on February 25, 2026, subject to Shareholders' Annual General Meeting approval on April 30, 2026
* Share buyback approved by the Board of Directors on February 25, 2026, expected to commence as soon as reasonably practicable, subject to market conditions
=== Executing the plan on growth, margin and efficiency ===
Line 90:
|}
</div>
*
*
*
*
=== Diversified franchise, well positioned in an attractive industry ===
Line 99:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+
! style="text-align:left" | Segment
! class="col-s" style="text-align:right" | Share
Line 120:
</div>
*
*
** Leading brand & high customer NPS
** Strong and diversified distribution
Line 129:
=== Laying the foundation for the next plan ===
*
** ''Clear tech'' and AI roadmap <sup>p. 8</sup>
** ''Driving efficiency'' across operations <sup>p. 8</sup>
** ''Enhancing capital'' allocation discipline <sup>p. 8</sup>
** ''Building resilience'' across the business <sup>p. 8</sup>
*
==
=== FY25 business performance ===
* ''Section 2'': FY25 Business Performance presented by Guillaume Borie, Global Head of Finance, Strategy, Underwriting, Risk, and Technology <sup>p. 9</sup>.
=== Strong delivery across our businesses ===
*
*
*
<div style="overflow-x:auto">
{| class="wikitable"
|+
! style="text-align:left" | Region (share of total GWP¹)
! class="col-m" style="text-align:right" | Gross written premiums
! class="col-m" style="text-align:right" | Underlying earnings
|-
| style="text-align:left" | ''France'' (27% of total GWP¹)
| class="col-m" style="text-align:right" | +6% to EUR 31bn
| class="col-m" style="text-align:right" | +7% to EUR 2.2bn
|-
| style="text-align:left" | ''Europe'' (38% of total GWP¹)
| class="col-m" style="text-align:right" | +6% to EUR 43bn
| class="col-m" style="text-align:right" | +9% to EUR 3.5bn
|-
| style="text-align:left" | ''AXA XL'' (17% of total GWP¹)
| class="col-m" style="text-align:right" | +4% to EUR 19bn
| class="col-m" style="text-align:right" | +9% to EUR 1.9bn
|-
| style="text-align:left" | ''Asia, Africa & EME-LATAM'' (18% of total GWP¹)
| class="col-m" style="text-align:right" | +13% to EUR 20bn
| class="col-m" style="text-align:right" | +6% to EUR 1.5bn
Line 173 ⟶ 175:
=== P&C | Strong margins, confidence in sustaining growth ===
*
**
* ''Underlying earnings'' +9% at constant FX to EUR 5.9bn <sup>p. 11</sup>.
* ''Retail and SME & Mid-market'' strategic outlook:
** ''
** ''Beyond 2025'': Investing to improve customer retention and expanding distribution footprint <sup>p. 11</sup>.
* ''AXA XL (Large & Specialty)'' strategic outlook:
** ''
** ''Beyond 2025'': Capitalizing on attractive growth opportunities and continued cycle management <sup>p. 11</sup>.
* ''Earnings drivers'' supporting performance:
**
** Higher investment income <sup>p. 11</sup>.
** Data & AI to further enhance customer experience and technical excellence <sup>p. 11</sup>.
=== L&H | Good momentum, well positioned to capture growth opportunities ===
*
* (donut) ''
* ''Underlying earnings'' +7% LFL to EUR 3.5bn (change FY25 vs. FY24 at constant FX) <sup>p. 12</sup>.
* ''Long-term business'' strategic priorities:
** ''
** ''Beyond 2025'': Capturing savings & retirement opportunity, sourcing best asset management products for our customers <sup>p. 12</sup>.
* ''Short-term business'' strategic priorities:
** ''
** ''Beyond 2025'': Capitalizing on demand for health & protection while further improving our margins <sup>p. 12</sup>.
* ''Strategic levers'' for growth and efficiency:
**
**
** Leveraging AI to reduce claims leakage & improve customer outcomes in Health <sup>p. 12</sup>.
==
=== FY25 financial performance ===
* ''Section 3'': FY25 Financial Performance presented by Alban de Mailly Nesle, Group CFO <sup>p. 13</sup>
=== P&C | Continued disciplined growth ===
Line 210 ⟶ 216:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ P&C GWP & other revenues by segment, FY24 vs FY25 <sup>p. 14</sup>
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change
! class="col-s" style="text-align:right" | o/w pricing
! class="col-s" style="text-align:right" | o/w volume
Line 239 ⟶ 245:
| style="text-align:right" | +2%
|-
| style="text-align:left; font-weight:bold" | Total
| style="text-align:right; font-weight:bold" | 56.5
| style="text-align:right; font-weight:bold" | 58.0
Line 247 ⟶ 253:
|}
</div>
* Continued pricing momentum and volume growth in Mid-market and SME
* Growing in lines of business with attractive margins while remaining focused on retention at AXA XL Insurance
* Growth supported by alternative capital
* Favorable pricing trends and strong growth in net new contracts
=== P&C | Delivering further margin expansion while enhancing reserve prudence ===
Line 256 ⟶ 262:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Combined ratio
! style="text-align:left" | Combined ratio
! class="col-s" style="text-align:right" | FY24
Line 287 ⟶ 293:
</div>
* Undiscounted CY loss ratio (ex Nat Cat) improved from:
** Margin expansion in Commercial lines SME & mid-market business and Personal lines reflecting
** Stable AXA XL Insurance margins at attractive levels reflecting disciplined cycle management
* Expense ratio improved reflecting the impact of efficiency measures, while continuing to invest in growth initiatives and technology
* Nat Cat charges
* Prior year reserve development
* Reserve prudence enhanced by taking advantage of a good year
=== P&C | Earnings growth from higher underwriting and financial result ===
Line 304 ⟶ 311:
| style="text-align:right" | 5,510
|-
| style="text-align:left" |
| style="text-align:right" | +292
|-
| style="text-align:left" |
| style="text-align:right" | +189
|-
| style="text-align:left" |
| style="text-align:right" | +435
|-
| style="text-align:left" |
| style="text-align:right" | -235
|-
Line 326 ⟶ 333:
|}
</div>
* Underlying earnings grew +9% at constant FX to EUR 5,872m
* Underwriting result improved from strong volume growth and improved all-year combined ratio while enhancing reserve prudence
* Investment income increased reflecting higher volumes and better reinvestment yields on fixed income assets
* Insurance finance expenses
* Forex impact was unfavorable, notably due to USD depreciation vs. EUR
=== Life & Health | Strong growth in premiums, positive net flows ===
Line 336 ⟶ 343:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ GWP
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | FY24
Line 342 ⟶ 349:
! class="col-s" style="text-align:right" | LFL Change
|-
| style="text-align:left" |
| style="text-align:right" | 34.5
| style="text-align:right" | 37.5
Line 367 ⟶ 374:
| style="text-align:right" | -7%
|-
| style="text-align:left" |
| style="text-align:right" | 17.5
| style="text-align:right" | 19.0
Line 382 ⟶ 389:
| style="text-align:right" | +4%
|-
| style="text-align:left" |
| style="text-align:right" | —
| style="text-align:right" | 12.9
| style="text-align:right" | +4%
|}
</div>
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Net flows by segment, FY24 vs FY25 <sup>p. 17</sup>
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
|-
| style="text-align:left; font-weight:bold" |
| style="text-align:right; font-weight:bold" | 1.5
| style="text-align:right; font-weight:bold" | 5.4
|-
| style="text-align:left" | Protection
| style="text-align:right" | —
| style="text-align:right" | 4.9
|-
| style="text-align:left" | Health
| style="text-align:right" | —
| style="text-align:right" | 2.7
|-
| style="text-align:left" | Unit-Linked
| style="text-align:right" | —
| style="text-align:right" | 1.5
|-
| style="text-align:left" | Capital light G/A
| style="text-align:right" | —
| style="text-align:right" | 1.2
|-
| style="text-align:left" | Traditional G/A
| style="text-align:right" | —
| style="text-align:right" | -5.0
|}
</div>
Line 423 ⟶ 433:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ PVEP
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | FY24
Line 429 ⟶ 439:
! class="col-s" style="text-align:right" | LFL Change
|-
| style="text-align:left; font-weight:bold" |
| style="text-align:right; font-weight:bold" | 50.9
| style="text-align:right; font-weight:bold" | 49.4
| style="text-align:right; font-weight:bold" | -2%
|-
| style="text-align:left" | Protection & Health
Line 453 ⟶ 463:
| style="text-align:right" | 1.7
| style="text-align:right" | -10%
|}
</div>
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ NB CSM and NBV, FY24 vs FY25 <sup>p. 18</sup>
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | LFL Change
|-
| style="text-align:left" |
| style="text-align:right" | 2.2
| style="text-align:right" | 2.2
| style="text-align:right" | +3%
|-
| style="text-align:left" |
| style="text-align:right" | 2.3
| style="text-align:right" | 2.2
| style="text-align:right" | stable
|}
</div>
* ''PVEP'' impacted by higher interest rates on discounting despite strong growth in Life volumes <sup>p. 18</sup>.
* ''NB CSM'' driven by robust Savings & Protection sales
* ''NBV'' broadly stable as strong growth in NB CSM balanced lower contribution from short-term multinational business in France <sup>p. 18</sup>.
* ''NBV margin'': 4.4% in FY24 → 4.5% in FY25 <sup>p. 18</sup>
=== Life & Health | Growth in new business driving Normalized CSM growth ===
Line 481 ⟶ 497:
|+ Contractual Service Margin rollforward, FY24 to FY25 <sup>p. 19</sup>
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" |
|-
| style="text-align:left" | FY24
Line 509 ⟶ 525:
</div>
* ''Normalized CSM'' up by +2%
* ''Economic variance'' reflecting government spreads tightening and positive equity market returns <sup>p. 19</sup>
* ''Operating variance'' driven by better margins and net flows that were more than offset by a reduction in the duration of Group Life business in Switzerland <sup>p. 19</sup>
* ''FX impact'' mainly from JPY and HKD depreciation <sup>p. 19</sup>
* (waterfall) ''Contractual Service Margin rollforward'' (in EUR billion): FY24 EUR 33.6bn (o/w Life EUR 25.8bn, o/w Health EUR 7.7bn) → New business CSM +EUR 2.2bn → Underlying return on in-force +EUR 1.3bn → CSM release -EUR 3.0bn (Normalized CSM growth +2%) → Economic variance +EUR 0.6bn → Operating variance -EUR 0.3bn → Affiliates, FX & other -EUR 1.4bn → FY25 EUR 33.0bn (o/w Life EUR 25.4bn, o/w Health EUR 7.6bn) <sup>p. 19</sup>
=== Life & Health | Strong momentum in both short-term and long-term business ===
Line 527 ⟶ 539:
! class="col-s" style="text-align:right" | Underlying earnings
|-
| style="text-align:left" | FY24 start
| style="text-align:right" | 3,323
|-
Line 542 ⟶ 554:
| style="text-align:right" | -27
|-
| style="text-align:left" | FY25 end
| style="text-align:right" | 3,501
|}
</div>
*
*
*
*
*
*
*
*
*
=== Growth in net income reflecting higher earnings & the gain from the sale of AXA IM ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Earnings and net income
! style="text-align:left" |
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
Line 592 ⟶ 599:
| style="text-align:right" | -
|-
| style="text-align:left" |
| style="text-align:right" |
| style="text-align:right" |
| style="text-align:right" |
|-
| style="text-align:left" | Non-financial flows
Line 602 ⟶ 609:
| style="text-align:right" | —
|-
| style="text-align:left; padding-left:1.5em" |
| style="text-align:right" | -
| style="text-align:right" | +2.2
Line 612 ⟶ 619:
| style="text-align:right" | —
|-
| style="text-align:left" |
| style="text-align:right" |
| style="text-align:right" |
| style="text-align:right" |
|}
</div>
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+
! style="text-align:left" | EUR
! class="col-s" style="text-align:right" |
|-
| style="text-align:left" |
| style="text-align:right" |
|-
| style="text-align:left" |
| style="text-align:right" |
|-
| style="text-align:left" |
| style="text-align:right" |
|-
| style="text-align:left" |
| style="text-align:right" |
|-
| style="text-align:left" |
| style="text-align:right" |
|-
| style="text-align:left" |
| style="text-align:right" |
|}
</div>
* ''Underlying earnings'' drivers:
** Strong performance from insurance businesses <sup>p. 21</sup>
** Stable holding cost, expected to remain at current level in 2026 <sup>p. 21</sup>
* ''Net income'' drivers:
** Higher net income mainly reflecting higher underlying earnings and the gain from the sale of AXA IM <sup>p. 21</sup>
** Lower financial flows reflecting unfavorable forex impact <sup>p. 21</sup>
* Change is at constant FX for underlying earnings and net income; change is on a reported basis for underlying earnings per share <sup>p. 21</sup>
* (bar) ''Underlying earnings per share'' (In Euro): EUR 3.59 in FY24 to EUR 3.86 in FY25 (+8%) <sup>p. 21</sup>
=== Shareholders' equity ===
* (stacked bar) ''Shareholders' equity'' Group share:
** ''FY24'': EUR 49.9bn total (comprising SHE excl. OCI EUR 58.0bn and Net OCI EUR -8.1bn) <sup>p. 22</sup>
** ''HY25'': EUR 45.5bn total (comprising SHE excl. OCI EUR 52.7bn and Net OCI EUR -7.2bn) <sup>p. 22</sup>
** ''FY25'': EUR 47.2bn total (comprising SHE excl. OCI EUR 54.0bn and Net OCI EUR -6.8bn) <sup>p. 22</sup>
* ''SHE (excl. OCI & undated subordinated debt)'': EUR 53.2bn in FY24 → EUR 47.0bn in HY25 → EUR 49.4bn in FY25 <sup>p. 22</sup>
* ''Debt gearing'': 20.6% in FY24 → 23.4% in HY25 → 22.3% in FY25 <sup>p. 22</sup>
* ''Underlying ROE'': 15.2% in FY24 → 17.5% in HY25 → 16.0% in FY25 <sup>p. 22</sup>
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Shareholders' equity roll-forward
! style="text-align:left" |
! class="col-s" style="text-align:right" | FY24 to FY25
! class="col-s" style="text-align:right" | HY25 to FY25
|-
| style="text-align:left" |
| style="text-align:right" | 49.9
| style="text-align:right" | 45.5
Line 710 ⟶ 714:
| style="text-align:right" | 0.3
|-
| style="text-align:left" |
| style="text-align:right" | 47.2
| style="text-align:right" | 47.2
|}
</div>
=== Higher organic cash remittance and robust cash position at Holding ===
*
**
** ''
* ''Remittance ratio'' remained stable at 82% in FY24 and 82% in FY25, based on ordinary cash remittance of EUR 7.1bn in FY24 and EUR 7.5bn in FY25 <sup>p. 23</sup>
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Holding cash position bridge FY24 to FY25
! style="text-align:left" |
! class="col-s" style="text-align:right" |
|-
| style="text-align:left" | ''FY24 Cash position''
| style="text-align:right" | 4.0
|-
| style="text-align:left" | Net cash remittance from subsidiaries
Line 751 ⟶ 757:
| style="text-align:right" | +3.1
|-
| style="text-align:left" | ''FY25 Cash position''
| style="text-align:right" | 5.6
|}
Line 762 ⟶ 768:
|+ Solvency II walk, FY24 to FY25 <sup>p. 24</sup>
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" |
! class="col-s" style="text-align:right" |
! class="col-s" style="text-align:right" | Solvency II ratio (pts)
|-
Line 807 ⟶ 813:
|}
</div>
* Foreseeable dividends accounted for -EUR 4.8bn.
* Provision for annual share buyback for 2026 accounted for -EUR 1.25bn.
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Key sensitivities of Solvency II
! style="text-align:left" | Sensitivity
! class="col-s" style="text-align:right" | Impact (pts)
|-
| style="text-align:left" | Interest rate +50bps
Line 829 ⟶ 838:
| style="text-align:right" | -4
|-
| style="text-align:left" | Listed Equity (
| style="text-align:right" | -1
|-
| style="text-align:left" | Listed Equity (
| style="text-align:right" | +2
|-
Line 846 ⟶ 855:
</div>
* Euro sovereign spreads sensitivity assumes a 50bps spread widening of the Euro sovereign bonds vs. the Euro swap curve, applied on sovereign and quasi-sovereign exposures.
* Credit rating migration sensitivity assumes 20% of corporate bonds (including private debt) held are downgraded by one full letter (3 notches).
=== Solvency II -impact of the end of grandfathering period and Solvency II revision ===
Line 856 ⟶ 862:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Solvency II ratio
! style="text-align:left" |
! class="col-
|-
| style="text-align:left" |
| style="text-align:right" | 224
|-
| style="text-align:left" | Grandfathering end impact on January 1, 2026
| style="text-align:right" | -
|-
| style="text-align:left" | Solvency II revision impact to come into effect in 1Q27
| style="text-align:right" | +
|}
</div>
* EUR 2.4bn grandfathered debt is no longer eligible as capital from January 1, 2026.
* No change is expected in organic capital generation
* Provides additional capital flexibility
* Estimated based on the Solvency Capital Requirement (SCR) and the amount of capital (EOF) under Solvency II as of January 1, 2026, as if the Solvency II revision had come into force on the same date.
* ''Grandfathering end impact'' on January 1, 2026 is -10pts to 215% <sup>p. 25</sup>.
=== Thomas Buberl, Group CEO conclusion ===
* ''
=== Conclusion ===
*
* ''
*
* ''
=== February 26, 2026 Q&A Full Year 2025 earnings ===
* ''
=== AXA Investor Relations | Keep in touch ===
*
*
<div style="overflow-x:auto">
Line 930 ⟶ 938:
== Appendices ==
* Section divider
=== Table of contents ===
*
*
*
*
=== Gross financial debt and maturity breakdown as of December 31st, 2025 ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Jan 1st 2026
|-
| style="text-align:left" | Tier 1
| style="text-align:right" | 4.8
| style="text-align:right" | 4.6
| style="text-align:right" | 3.2
|-
| style="text-align:left" | Tier 2
| style="text-align:right" | 10.8
| style="text-align:right" | 12.2
| style="text-align:right" | 11.3
|-
| style="text-align:left" | Senior debt
| style="text-align:right" | 3.5
| style="text-align:right" | 3.5
| style="text-align:right" | 5.8
|-
| style="text-align:left; font-weight:bold" | Total
| style="text-align:right; font-weight:bold" | 19.2
| style="text-align:right; font-weight:bold" | 20.3
| style="text-align:right; font-weight:bold" | 20.3
|-
| style="text-align:left" | Debt gearing
| style="text-align:right" | 20.6%
| style="text-align:right" | 22.3%
| style="text-align:right" | —
|}
</div>
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Contractual maturity breakdown <sup>p. 32</sup>
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | Tier 1
! class="col-s" style="text-align:right" | Tier 2
! class="col-s" style="text-align:right" | Senior debt
|-
| style="text-align:left" | 2028
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 0.5
|-
| style="text-align:left" | 2030
| style="text-align:right" | —
| style="text-align:right" | 0.7
| style="text-align:right" | 0.9
|-
| style="text-align:left" | 2031-2039
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 1.5
|-
| style="text-align:left" | ≥2040
| style="text-align:right" | —
| style="text-align:right" | 10.8
| style="text-align:right" | 0.5
|-
| style="text-align:left" | Undated
| style="text-align:right" | 4.6
| style="text-align:right" | 0.7
| style="text-align:right" | —
|-
| style="text-align:left" | Grandfathered debt (contractual)
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Tier 1 Undated
| style="text-align:right" | 1.4
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Tier 2 2030
| style="text-align:right" | —
| style="text-align:right" | 0.7
| style="text-align:right" | —
|-
| style="text-align:left" | Tier 2 ≥2040
| style="text-align:right" | —
| style="text-align:right" | 0.2
| style="text-align:right" | —
|}
</div>
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Economic maturity breakdown <sup>p. 32</sup>
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | Tier 1
! class="col-s" style="text-align:right" | Tier 2
! class="col-s" style="text-align:right" | Senior debt
|-
| style="text-align:left" | 2026
| style="text-align:right" | 0.1
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | 2027
| style="text-align:right" | —
| style="text-align:right" | 2.4
| style="text-align:right" | —
|-
| style="text-align:left" | 2028
| style="text-align:right" | 0.1
| style="text-align:right" | —
| style="text-align:right" | 0.5
|-
| style="text-align:left" | 2029
| style="text-align:right" | —
| style="text-align:right" | 2.0
| style="text-align:right" | —
|-
| style="text-align:left" | 2030
| style="text-align:right" | —
| style="text-align:right" | 0.7
| style="text-align:right" | 0.9
|-
| style="text-align:left" | 2031-2039
| style="text-align:right" | 0.4
| style="text-align:right" | 6.4
| style="text-align:right" | 1.5
|-
| style="text-align:left" | ≥2040
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 0.5
|-
| style="text-align:left" | Undated
| style="text-align:right" | 4.0
| style="text-align:right" | 0.7
| style="text-align:right" | —
|-
| style="text-align:left" | Grandfathered debt (economic)
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Tier 1 2026
| style="text-align:right" | 0.1
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Tier 1 2028
| style="text-align:right" | 0.1
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Tier 1 2031-2039
| style="text-align:right" | 0.4
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Tier 1 Undated
| style="text-align:right" | 0.8
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Tier 2 2030
| style="text-align:right" | —
| style="text-align:right" | 0.7
| style="text-align:right" | —
|-
| style="text-align:left" | Tier 2 ≥2040
| style="text-align:right" | —
| style="text-align:right" | 0.2
| style="text-align:right" | —
|}
</div>
* In January 2026, AXA called the remaining Tier 2 grandfathered GBP 139m due 2054 callable 2034 (5.625% issued January 2014) and the Tier 1 grandfathered EUR 250m perpetual callable 2010 floating (issued January 2005).
* Economic maturity accounts for the first date of step-up calls on institutionally placed subordinated debt.
* For Solvency II RT1 debt with no step-up, the undated nature of the instrument is retained for economic maturity.
=== General account invested assets ===
* ''Total General Account'' invested assets at EUR 450bn <sup>p. 33</sup>.
* ''Duration gap'' at -0.4 year <sup>p. 33</sup>.
* (donut) ''FY25 General Account invested assets'': EUR 450bn total; mix includes Fixed income, Real estate, Infrastructure equity, Listed equities, Private equity and hedge funds, Cash, and Policy loans <sup>p. 33</sup>.
* ''Other fixed income'' includes Asset Backed Securities (EUR 25bn), Residential Loans (EUR 16bn), Commercial & Agricultural Loans (EUR 7bn), and Agency Pools (EUR 8bn) <sup>p. 33</sup>.
* ''Listed equities'' includes hedges; listed equities excluding hedges at EUR 14bn <sup>p. 33</sup>.
* ''Private equity and hedge funds'' includes Private Equity (EUR 17bn), Hedge Funds (EUR 5bn), and Non-listed Equities (EUR 1bn) <sup>p. 33</sup>.
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Invested assets
! style="text-align:left" |
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | %
|-
| style="text-align:left" |
| style="text-align:right" | 345
| style="text-align:right" | 77%
Line 995 ⟶ 1,156:
| style="text-align:right" | 27%
|-
| style="text-align:left" | ''o/w Other fixed income
| style="text-align:right" | 56
| style="text-align:right" | 13%
|-
| style="text-align:left" |
| style="text-align:right" | 41
| style="text-align:right" | 9%
|-
| style="text-align:left" |
| style="text-align:right" | 10
| style="text-align:right" | 2%
|-
| style="text-align:left" |
| style="text-align:right" | 10
| style="text-align:right" | 2%
|-
| style="text-align:left" |
| style="text-align:right" | 23
| style="text-align:right" | 5%
|-
| style="text-align:left" |
| style="text-align:right" | 19
| style="text-align:right" | 4%
|-
| style="text-align:left" |
| style="text-align:right" | 2
| style="text-align:right" | 0%
|-
| style="text-align:left" |
| style="text-align:right" |
| style="text-align:right" |
|}
</div>
=== Structured and private credit assets ===
* ''Total structured and private credit assets'' stood at EUR 69bn, representing 15% of the total General Account portfolio, with 54% participating <sup>p. 34</sup>.
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Structured and
! style="text-align:left" | Invested assets (100%)
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | % of total G/A¹ portfolio
Line 1,066 ⟶ 1,225:
| style="text-align:right" | 10
| style="text-align:right" | 2%
| style="text-align:right" | - Strong diversification with EUR 8m average ticket - Investments through SMAs with strict underwriting guidelines
|-
| style="text-align:left" | Other
Line 1,073 ⟶ 1,232:
| style="text-align:right" | —
|-
| style="text-align:left" |
| style="text-align:right" |
| style="text-align:right" |
| style="text-align:right" | o/w 54% participating
|}
</div>
*
=== Investment portfolio | Fixed
<div style="overflow-x:auto">
{| class="wikitable fintable"
! style="text-align:left" | Asset mix
! class="col-s" style="text-align:right" | Share
|-
| style="text-align:left" | Government bonds & related
| style="text-align:right" | 32%
|-
| style="text-align:left" | Investment grade credit
| style="text-align:right" | 40%
|-
| style="text-align:left" | ABS/CLO/IG fund financing
| style="text-align:right" | 21%
|-
| style="text-align:left" | Below investment grade credit
| style="text-align:right" | 7%
|}
</div>
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ FY25 Fixed Income Reinvestment Yield <sup>p. 35</sup>
! style="text-align:left" | Fixed Income Type
! class="col-s" style="text-align:right" | Yield
|-
| style="text-align:left" | Public fixed income
| style="text-align:right" | 3.5%
|-
| style="text-align:left" | Private & Structured fixed income
| style="text-align:right" | 4.7%
|-
| style="text-align:left; font-weight:bold" | Total fixed income
| style="text-align:right; font-weight:bold" | 3.9%
|}
</div>
* Fixed income reinvestment totaled EUR 57bn in FY25 <sup>p. 35</sup>
* Reinvestment yield achieved at 3.9% on EUR 57bn fixed income <sup>p. 35</sup>
** Average duration of 9 years <sup>p. 35</sup>
** Private & Structured Credit reinvestment of EUR 19.7bn at 4.7% yield, including CLOs, ABS, Infra & CRE debt, Fund financing, and Private HY <sup>p. 35</sup>
** Strategic shift characterized by a gradual transition from alternative total return assets to Private & Structured credit <sup>p. 35</sup>
=== Table of contents ===
* ''Debt and Invested Assets'' on page 31 <sup>p. 36</sup>
* ''Additional P&C disclosures'' on page 36 <sup>p. 36</sup>
* ''Additional IFRS17 disclosures'' on page 41 <sup>p. 36</sup>
* ''Sustainability'' on page 44 <sup>p. 36</sup>
=== AXA XL Insurance | Large Commercial & Specialty business ===
Line 1,105 ⟶ 1,297:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ FY25 GWP by line of business
! style="text-align:left" |
! class="col-s" style="text-align:right" |
|-
| style="text-align:left" |
| style="text-align:right" | 35%
|-
| style="text-align:left" | Property
| style="text-align:right" | 29%
|-
| style="text-align:left" | Specialty
| style="text-align:right" | 19%
|-
| style="text-align:left" | Professional lines (including Cyber)
| style="text-align:right" | 17%
|}
</div>
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ FY25 GWP by geography <sup>p. 37</sup>
! style="text-align:left" | Geography
! class="col-s" style="text-align:right" | Share
|-
| style="text-align:left" | Americas
| style="text-align:right" | 46%
|-
| style="text-align:left" | Europe & APAC
| style="text-align:right" | 35%
|-
| style="text-align:left" | UK & Lloyds
| style="text-align:right" | 19%
|}
</div>
<div style="overflow-x:auto">
{| class="wikitable"
|+ Profitability vs Ex-price growth (%) <sup>p. 37</sup>
! style="text-align:left" | Line of business
! class="col-m" style="text-align:right" | Profitability
! class="col-m" style="text-align:right" | Ex-price growth
|-
| style="text-align:left" | Property
| class="col-m" style="text-align:right" | high
| class="col-m" style="text-align:right" | high
|-
| style="text-align:left" | Specialty
| class="col-m" style="text-align:right" | medium-high
| class="col-m" style="text-align:right" | medium-high
|-
| style="text-align:left" | Casualty
| class="col-m" style="text-align:right" | medium
| class="col-m" style="text-align:right" | medium
|-
| style="text-align:left" | Professional lines
| class="col-m" style="text-align:right" | lower
| class="col-m" style="text-align:right" | lower
|}
</div>
* Business diversification is well balanced across lines of business and geographies <sup>p. 37</sup>
* Market leadership positions AXA XL in the top 3 globally for <sup>p. 37</sup>:
** Multinational Programs <sup>p. 37</sup>
** Marine <sup>p. 37</sup>
** Fine Art & Specie <sup>p. 37</sup>
*
=== P&C | Focus on
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Claims and
! style="text-align:left" | %
! class="col-s" style="text-align:right" | FY18
Line 1,162 ⟶ 1,384:
|-
| style="text-align:left" | Claims reserves ratio (IFRS4 basis)
| style="text-align:right" | 179
| style="text-align:right" | 185
| style="text-align:right" | 193
| style="text-align:right" | 188
| style="text-align:right" | 189
| style="text-align:right" | —
| style="text-align:right" | —
Line 1,176 ⟶ 1,398:
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 198
| style="text-align:right" | 195
| style="text-align:right" | 180
| style="text-align:right" | 175
|-
| style="text-align:left" | Technical reserves ratio (IFRS4 basis)
| style="text-align:right" | 213
| style="text-align:right" | 227
| style="text-align:right" | 233
| style="text-align:right" | 226
| style="text-align:right" | 227
| style="text-align:right" | —
| style="text-align:right" | —
Line 1,196 ⟶ 1,418:
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 234
| style="text-align:right" | 232
| style="text-align:right" | 216
| style="text-align:right" | 210
|}
</div>
* Technical reserves definition includes net undiscounted claims reserves and unearned premium reserves <sup>p. 38</sup>.
=== P&C | 2026 Simplified Group Nat Cat reinsurance program 1 ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Insurance segment occurrence protection
! style="text-align:left" |
! class="col-s" style="text-align:right" | Retention
! class="col-m" style="text-align:right" | Capacity
|-
| style="text-align:left" | EU Windstorm
|
|
|-
| style="text-align:left" | Europe Flood
|
|
|-
| style="text-align:left" | Europe Earthquake
|
|
|-
| style="text-align:left" | NA Hurricane
|
|
|-
| style="text-align:left" | NA Earthquake
|
|
|-
| style="text-align:left" | Per other perils
|
|
|}
</div>
* Retention levels remained stable in 2026 compared to 2025 <sup>p. 39</sup>.
* (diagram) ''Reinsurance segment'' (illustrative):
*
=== P&C | AXA Group earnings deviation with different levels of Nat Cat cost 1 in 2026 ===
Line 1,247 ⟶ 1,468:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Group underlying earnings deviation to average Nat Cat charges in 2026
! style="text-align:left" |
! class="col-s" style="text-align:right" | EUR billion
|-
Line 1,290 ⟶ 1,511:
|}
</div>
* ''More severe years'' result in a negative deviation in ca. 40% of cases <sup>p. 40</sup>.
* ''
* Natural catastrophe cost defined as Aggregate Exceedance Probability (AEP) of all natural perils worldwide, net of tax and reinsurance. Deviation is compared to a normalized level, which are costs associated with natural catastrophes expected in an average year (ca. 4.5 points of estimated FY25 GEP, undiscounted and net of reinsurance). <sup>p. 40</sup>
=== Table of contents ===
* ''Debt and Invested Assets'' <sup>p. 31</sup>
* ''Additional P&C disclosures'' <sup>p. 36</sup>
* ''Additional IFRS17 disclosures'' <sup>p. 41</sup>
* ''Sustainability'' <sup>p. 44</sup>
=== P&C | Margin analysis ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ P&C
! style="text-align:left" |
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change
|-
| style="text-align:left" | ''
| style="text-align:right" | 2,778
| style="text-align:right" | +707
|-
| style="text-align:left" |
| style="text-align:right" | 2,009
| style="text-align:right" | +115
|-
| style="text-align:left" |
| style="text-align:right" | 622
| style="text-align:right" | -341
|-
| style="text-align:left" |
| style="text-align:right" | 3,988
| style="text-align:right" | +435
|-
| style="text-align:left" |
| style="text-align:right" | -1,358
| style="text-align:right" | -235
|-
| style="text-align:left" | ''Underlying Earnings before tax''
| style="text-align:right" | 8,040
| style="text-align:right" | +681
|-
| style="text-align:left" | Tax
| style="text-align:right" | -2,060
| style="text-align:right" | -169
|-
| style="text-align:left" | Affiliates, Minority interests & Other
| style="text-align:right" | -108
| style="text-align:right" | -10
|-
| style="text-align:left" | ''Underlying Earnings''
| style="text-align:right" | 5,872
| style="text-align:right" | +501
|}
</div>
* ''Gross earned premiums'' EUR 57,656m (+6%) <sup>p. 42</sup>
* ''Undiscounted combined ratio'' 95.2% (-1.0pt); of which Nat Cats was 3.4% (-0.4pt) <sup>p. 42</sup>
* ''Discounting ratio'' -3.5% (+0.0pt in Combined Ratio points) <sup>p. 42</sup>
* ''Net claims reserves'' for current accident year at EUR 19.0bn; duration of 4.0 years; discount rate of 2.8% <sup>p. 42</sup>
* ''PYD ratio'' -1.1% (+0.7pt) <sup>p. 42</sup>
* ''Average assets'' for FY25 at EUR 115bn; asset book yield at 3.5%; reinvestment yield on fixed income assets at 4.3% <sup>p. 42</sup>
* ''Reserves at locked-in rate'' for FY24 at EUR 71bn; liability book yield at 1.9% <sup>p. 42</sup>
* ''Underlying earnings growth'' +9% vs. FY24 at constant FX <sup>p. 42</sup>
* ''Discount rate sensitivity'': FY25 sensitivity to current accident year discount rate changes (parallel shift of the full-year average yield curve):
** +25bps: +EUR 0.2bn <sup>p. 42</sup>
** -25bps: -EUR 0.2bn <sup>p. 42</sup>
* ''Insurance finance expenses'': 2026e pre-tax expected at ~EUR -1.4bn <sup>p. 42</sup>
** Sensitivity of 2026e expenses to changes in 2025 current AY discount: +25bps ~EUR -50m; -25bps ~EUR +50m <sup>p. 42</sup>
=== L&H | Margin analysis ===
* ''L&H margin analysis'' includes scope impact <sup>p. 43</sup>.
* ''Short-term technical margin'' +EUR 60m to EUR 479m, including the recapture of Laya <sup>p. 43</sup>.
* ''Gross earned premiums'' +10% to EUR 17,416m <sup>p. 43</sup>.
* ''All year combined ratio'' 97.2%, improved 0.1pts <sup>p. 43</sup>.
* ''Long-term technical margin'' +EUR 156m to EUR 2,804m <sup>p. 43</sup>.
** ''CSM release'' +EUR 215m to EUR 2,954m <sup>p. 43</sup>.
** ''Technical experience'' decreased EUR 58m to EUR -150m <sup>p. 43</sup>.
* ''Investment income'' (non-VFA only) decreased EUR 1m to EUR 2,484m <sup>p. 43</sup>.
** ''Average assets'' (FY25) at EUR 98bn with an asset book yield of 2.5% and FY25 reinvestment yield on fixed income assets of 3.8% <sup>p. 43</sup>.
* ''Insurance finance expenses'' (non-VFA only) increased EUR 9m to EUR -1,538m <sup>p. 43</sup>.
** ''Reserves at locked-in rate'' (FY24) at EUR 62bn with a liability book yield of 2.5% <sup>p. 43</sup>.
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+
! style="text-align:left" |
! class="col-s" style="text-align:right" |
! class="col-s" style="text-align:right" | Change
|-
| style="text-align:left" |
| style="text-align:right" |
| style="text-align:right" | +60
|-
| style="text-align:left" | Long-
| style="text-align:right" |
| style="text-align:right" | +156
|-
| style="text-align:left" | Investment Income (non-VFA only)
| style="text-align:right" | 2,484
| style="text-align:right" | -1
|-
| style="text-align:left" | Insurance Finance Expenses (non-VFA only)
| style="text-align:right" | -1,538
| style="text-align:right" | -9
|}
</div>
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+
! style="text-align:left" |
! class="col-s" style="text-align:right" |
! class="col-s" style="text-align:right" | Change
|-
| style="text-align:left" |
|
| style="text-align:right" | +205
|-
| style="text-align:left" |
|
| style="text-align:right" | 65
|-
| style="text-align:left" | Affiliates, Minority interests & Other
| style="text-align:right" | 72
| style="text-align:right" | -51
|-
| style="text-align:left" | Underlying Earnings
| style="text-align:right" | 3,501
| style="text-align:right" | +219
|}
</div>
* ''
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Life & Health FY25 CSM
! style="text-align:left" | Sensitivity
! class="col-s" style="text-align:right" | Impact
|-
| style="text-align:left" |
| style="text-align:right" |
|-
| style="text-align:left" | Interest rates +50bps
Line 1,431 ⟶ 1,684:
</div>
=== Table of contents ===
* ''Debt and Invested Assets'' <sup>p. 31</sup>
* ''Additional P&C disclosures'' <sup>p. 36</sup>
* ''Additional IFRS17 disclosures'' <sup>p. 41</sup>
* ''Sustainability'' <sup>p. 44</sup>
=== Expanding AXA's role in society: AXA for Progress Index 1 ===
Line 1,477 ⟶ 1,695:
<div style="overflow-x:auto">
{| class="wikitable"
|+ ESG
! style="text-align:left" | Category
! class="col-m" style="text-align:right" | Target
! class="col-m" style="text-align:right" |
|-
| style="text-align:left" | Climate transition financing
Line 1,490 ⟶ 1,708:
| class="col-m" style="text-align:right" | EUR 1.4bn
|-
| style="text-align:left" | Transition underwriting (cumulative 2024-2026)
| class="col-m" style="text-align:right" | EUR 6bn in P&C GWP
| class="col-m" style="text-align:right" | EUR 4.6bn
|-
| style="text-align:left" | Climate adaptation solutions (cumulative 2024-2026)
| class="col-m" style="text-align:right" | >20,000
| class="col-m" style="text-align:right" | 19,698 (cumulative 2024-2025)
|-
| style="text-align:left" | Inclusive insurance customers
Line 1,503 ⟶ 1,721:
|-
| style="text-align:left" | Climate adaptation training
| class="col-m" style="text-align:right" | >80,000 employees
| class="col-m" style="text-align:right" | 46,420
|-
| style="text-align:left" | Carbon emissions reduction
| class="col-m" style="text-align:right" | -50% by 2030
| class="col-m" style="text-align:right" | -64%
|-
| style="text-align:left" | Employee volunteering
| class="col-m" style="text-align:right" | 50% of employees
| class="col-m" style="text-align:right" | 56%
|}
Line 1,520 ⟶ 1,738:
<div style="overflow-x:auto">
{| class="wikitable"
|+ ESG
! style="text-align:left" | Rating Agency
! class="col-
|-
| style="text-align:left" | S&P Global percentile
| class="col-
|-
| style="text-align:left" | MSCI
| class="col-
|-
| style="text-align:left" | CDP
| class="col-
|-
| style="text-align:left" | Morningstar Sustainalytics
| class="col-
|-
| style="text-align:left" | FTSE Russell
| class="col-
|}
</div>
* The Corporate Sustainability Assessment (CSA) ranking is a key performance indicator for AXA Group, used to calculate the grant of Long-Term Incentives (specifically AXA Restricted Shares), with results as of February 6th, 2026 <sup>p. 46</sup>.
* ''Morningstar Sustainalytics rating'': 2025 ESG Risk Rating of 17.0 – Low risk <sup>p. 46</sup>
* ''FTSE Russell score'': 4.3/5 in FTSE4Good Index Series <sup>p. 46</sup>
=== Scope ===
*
*
*
*
**
**
**
**
*
*
*
=== Glossary ===
*
*
*
*
*
*
*
*
*
*
*
*
*
=== February 26, 2026 Thank you Full Year 2025 earnings ===
* ''Closing slide'' for the AXA Full Year 2025 Earnings
== Abbreviations ==
*
*
*
* ''AEP'': Aggregate Exceedance Probability
* ''
* ''
* ''
*
* ''AXA XL'': AXA Corporate Solutions and XL Catlin
* ''
* ''
* ''
* ''
* ''
* ''CSA'': Corporate Sustainability Assessment
* ''
* ''
* ''
* ''
* ''EOF'': Eligible Own Funds
* ''
* ''ESG'': Environmental, Social, and Governance
* ''ESMA'': European Securities and Markets Authority
* ''
* ''EUR'': Euro
* ''
* ''GAAP'': Generally Accepted Accounting Principles
* ''
* ''
* ''
* ''
* ''HY'': High Yield
* ''
* ''IFRS'': International Financial Reporting Standards
* ''
* ''
* ''
* ''LFL'': Like-for-Like
* ''
* ''MSCI'': Morgan Stanley Capital International
* ''
* ''NB CSM'': New Business Contractual Service Margin
* ''
* ''
* ''
* ''
* ''
* ''PE'': Private Equity
* ''
* ''
* ''
* ''
* ''
* ''SHE'': Shareholders' Equity
* ''SME'': Small and Medium-sized Enterprises
* ''TVOG'': Time Value of Options and Guarantees
* ''
* ''
* ''
* ''VAT'': Value Added Tax
* ''VFA'': Variable Fee Approach
| |||